Hepatitis D (HDV) – Drug Pipeline Landscape, 2022 Market – Pipeline Analysis Demonstrates Novel 230+ Therapies at the Horizon Expected to Transform the Treatment Paradigm | Antios Therapeutics, Inc, Eiger BioPharmaceuticals Inc, Gilead Sciences Inc, Hepatera Ltd., Janssen Research & Development, LLC, PharmaEssentia,
As per Global Insight services’ assessment, about 20+ prominent pharma and biotech giants are working on 20+ drugs in the Hepatitis D (HDV) – Drug …